Clinical Edge Journal Scan

Clinical Edge Journal Scan

Subcutaneous injection of diclofenac sodium is effective against acute migraine

Publish date: May 22, 2022

Read More

Clinical Edge Journal Scan

Migraine: Ubrogepant therapy yields favorable 2-hour outcomes in triptan insufficient responders

Publish date: May 22, 2022

Read More

Clinical Edge Journal Scan

Galcanezumab reduces acute headache medication use in treatment-resistant migraine

Publish date: May 22, 2022

Read More

Clinical Edge Journal Scan

Migraine: Suboptimal first-dose responders may benefit from a second dose of eptinezumab

Publish date: May 22, 2022

Read More

Clinical Edge Journal Scan

Evidence of real-world effectiveness of erenumab against chronic migraine

Publish date: May 22, 2022

Read More

Clinical Edge Journal Scan

Fremanezumab can prevent migraine across a broad real-world patient population

Publish date: May 22, 2022

Read More

Clinical Edge Journal Scan

Clinical Edge Journal Scan Commentary: Migraine May 2022

Author:: Thomas Berk, MD

Publish date: May 5, 2022

Read More

Clinical Edge Journal Scan

Meta-analysis backs the clinically significant effects of transcutaneous nerve stimulation in migraine

Publish date: April 25, 2022

Read More

Clinical Edge Journal Scan

Fremanezumab effective and safe for high-frequency episodic and chronic migraine in real world

Publish date: April 25, 2022

Read More

Clinical Edge Journal Scan

CGRP mAb vs. standard treatments offer better adherence and persistence in migraine

Publish date: April 25, 2022

Read More

Pages

FULL MENU FULL MENU
More
- MDedge